Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea

Keyphrases

• 2-phase 14%
• Abdominal Bloating 28%
• Abdominal Discomfort 28%
• Abdominal Pain 71%
• Abdominal Symptoms 14%
• Adequate Relief 28%
• Alleviation 14%
• Bowel Dysfunction 14%
• Bowel Movement 28%
• Change from Baseline 28%
• Composite Endpoint 28%
• Data Presentation 14%
• Disparate Data 100%
• Efficacy Endpoint 14%
• Eluxadoline 100%
• Global Symptom Score 28%
• Irritable Bowel Syndrome 100%
• Locally Active 14%
• Multiple Domains 14%
• Novel Modalities 100%
• Opioid Antagonist 28%
• Phase II Study 14%
• Phase II Trial 14%
• Placebo 57%
• Placebo-controlled 14%
• Progress Management 14%
• Radar Plot 100%
• Response Rate 14%
• Rome III Criteria 14%
• Simultaneous Improvement 14%
• Stool Consistency 42%
• Twice Daily 14%
• Visual Evaluation 14%

Medicine and Dentistry

• Abdominal Discomfort 33%
• Abdominal Pain 83%
• Bloating 33%
• Diarrhea 100%
• Eluxadoline 100%
• Irritable Bowel Syndrome 100%
• Opiate Agonist 16%
• Opiate Antagonist 16%
• Placebo 83%

Pharmacology, Toxicology and Pharmaceutical Science

• Abdominal Discomfort 33%
• Abdominal Pain 83%
• Bloating 33%
• Diarrhea 100%
• Eluxadoline 100%
• Irritable Colon 100%
• Narcotic Antagonist 16%
• Opiate Agonist 16%
• Placebo 83%